Prostaglandin E 2 blocks menadione-induced apoptosis through the Ras/Raf/Erk signaling pathway in promonocytic leukemia cell lines

Abstract

Altered oxidative stress has long been observed in cancer cells, and this biochemical property of cancer cells represents a specific vulnerability that can be exploited for therapeutic benefit. The major role of an elevated oxidative stress for the efficacy of molecular targeted drugs is under investigation. Menadione is considered an attractive model for the study of oxidative stress, which can induce apop-tosis in human leukemia HL-60 cell lines. Prostaglandin E 2 (PGE 2) via its receptors not only promotes cell survival but also reverses apoptosis and promotes cancer progression. Here, we present evidence for the biological role of PGE 2 as a protective agent of oxidative stress-induced apop-tosis in monocytic cells. Pretreatment of HL-60 cells with PGE 2 markedly ameliorated the menadione-induced apop-tosis and inhibited the degradation of PARP and lamin B. The EP 2 receptor antagonist AH6809 abrogated the inhibitory effect of PGE 2, suggesting the role of the EP 2/cAMP system. The PKA inhibitor H89 also reversed apoptosis and decreased the PKA activity that was elevated 10-fold by PGE 2. The treatment of HL-60 cells with NAC or zinc chloride showed a similar protective effect as with PGE 2 on menadione-treated cells. Furthermore, PGE 2 activated the Ras/Raf/MEK pathway, which in turn initiated ERK activation, and ultimately protected menadione-induced apo-ptosis. These results imply that PGE 2 via cell survival pathways may protect oxidative stress-induced apoptosis in monocytic cells. This study warrants further pre-clinical investigation as well as application towards leukemia clinics. © 2012 KSMCB.